Abstract
Chronic lymphocytic leukemia (CLL) affects primarily older people and may not require treatment for a while after diagnosis. Targeted therapies which change B-cell signaling are nowthepreferredfirst-linetreatment.Thesetherapieshavereplacedchemoimmunotherapy which should now be used rarely.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 12-15 |
| Number of pages | 4 |
| Journal | Journal of Managed Care Medicine |
| Volume | 25 |
| Issue number | 1 |
| State | Published - 2022 |
| Externally published | Yes |
ASJC Scopus subject areas
- Health Policy